SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 2, 2012, Pages 253-260

  Thaikoottathil, Jyoti V ^a   Martin, Richard J ^a   Di, Peter Y ^b   Minor, Maisha ^a   Case, Stephanie ^a   Zhang, Bicheng ^a   Zhang, Gongyi ^a   Huang, Hua ^a   Chu, Hong Wei ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alveolar macrophage; Asthma; Eotaxin 2; SPLUNC1; Th2 cytokines

Indexed keywords

EOTAXIN 2; OVALBUMIN; PROTEIN; PROTEIN SHORT PALATE, LUNG AND NASAL EPITHELIUM CLONE 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TH1 TH2 BALANCE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL24; EOSINOPHILS; GLYCOPROTEINS; HEK293 CELLS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PHOSPHOPROTEINS; PNEUMONIA; RECOMBINANT PROTEINS; TH2 CELLS;

MURINAE; MUS;

EID: 84864554584     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0064OC     Document Type: Article

References (51)

1. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ 2009;181:E181-E190.
2. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984.
3. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989;66:1059-1064. (Pubitemid 19091329)
4. Michel O. Role of house-dust endotoxin exposure in aetiology of allergy and asthma. Mediators Inflamm 2001;10:301-304. (Pubitemid 34084407)
5. Reed CE, Milton DK. Endotoxin-stimulated innate immunity: a contributing factor for asthma. J Allergy Clin Immunol 2001;108:157-166. (Pubitemid 32735395)
6. Plotz SG, Lentschat A, Behrendt H, Plotz W, Hamann L, Ring J, Rietschel ET, Flad HD, Ulmer AJ. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 2001;97:235-241. (Pubitemid 32061266)
7. + T-lymphocytes in an exacerbation of murine chronic asthma. Am J Pathol 2010;177:1657-1664.
8. Catena E, Mazzarella G, Peluso GF, Micheli P, Cammarata A, Marsico SA. Phenotypic features and secretory pattern of alveolar macrophages in atopic asthmatic patients. Monaldi Arch Chest Dis 1993;48:6-15. (Pubitemid 23155296)
9. Zhou HD, Fan SQ, Zhao J, Huang DH, Zhou M, Liu HY, Zeng ZY, Yang YX, Huang H, Li XL, et al. Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol 2006;125:315-324. (Pubitemid 43228205)
10. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, et al. Function and regulation of SPLUNC1 protein in mycoplasma infection and allergic inflammation. J Immunol 2007;179:3995-4002.
11. Gally F, Di YP, Smith SK, Minor MN, Liu Y, Bratton DL, Frasch SC, Michels NM, Case SR, Chu HW. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am J Pathol 2011;178:2159-2167.
12. Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, Leikauf GD, Kolls JK, Di YP. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol 2011;187:382-390.
13. Jonasson S, Hedenstierna G, Hjoberg J. Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma. J Appl Physiol 2010;109:521-531.
14. Lloyd C. Chemokines in allergic lung inflammation. Immunology 2002;105:144-154. (Pubitemid 34146680)
15. Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, Kay AB. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999;163:3976-3984. (Pubitemid 29450927)
16. Heiman AS, Abonyo BO, Darling-Reed SF, Alexander MS. Cytokinestimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26). J Interferon Cytokine Res 2005;25:82-91. (Pubitemid 40250350)
17. Ben-Yehuda C, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N. Airway eosinophil accumulation and eotaxin-2/CCL24 expression following allergen challenge in BALB/c mice. Exp Lung Res 2008;34:467-479.
18. Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 2005;175:5341-5350. (Pubitemid 41456420)
19. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, Kay AB. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999;163:6321-6329.
20. Wu Q, Martin RJ, LaFasto S, Chu HW. A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway. Clin Exp Allergy 2009;39:1754-1763.
21. Watanabe K, Jose PJ, Rankin SM. Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. J Immunol 2002;168:1911-1918. (Pubitemid 34135793)
22. Chu HW, Gally F, Thaikoottathil J, Janssen-Heininger YM, Wu Q, Zhang G, Reisdorph N, Case S, Minor M, Smith S, et al. SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling. Respir Res 2010;11:155.
23. Monick MM, Hunninghake GW. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J 2002;20:210-222. (Pubitemid 34822945)
24. DeFranco AL, Hambleton J, McMahon M, Weinstein SL. Examination of the role of MAP kinase in the response of macrophages to lipopolysaccharide. Prog Clin Biol Res 1995;392:407-420.
25. Bhattacharjee A, Pal S, Feldman GM, Cathcart MK. HCK is a key regulator of gene expression in alternatively activated human monocytes. J Biol Chem 2011;286:36709-36723.
26. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, Homer RJ, Zhu Z, Rincon M, Mossman BT, Elias JA. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 2006;116:163-173. (Pubitemid 43121801)
27. Olsson S, Sundler R. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol Immunol 2006;43:607-612. (Pubitemid 41785388)
28. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
29. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J ExpMed 1995;181:537-546.
30. Varin A, Mukhopadhyay S, Herbein G, Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010;115:353-362.
31. Roy S, Charboneau R, Melnyk D, Barke RA. Interleukin-4 regulates macrophage interleukin-12 protein synthesis through a c-Fos mediated mechanism. Surgery 2000;128:219-224. (Pubitemid 30622486)
32. Wenzel SE, Trudeau JB, Barnes S, Zhou X, Cundall M, Westcott JY, McCord K, Chu HW. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 2002;169:4613-4619. (Pubitemid 35178241)
33. Wu Q, Martin RJ, Lafasto S, Efaw BJ, Rino JG, Harbeck RJ, Chu HW. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med 2008;177:720-729. (Pubitemid 351490559)
34. Case SR, Martin RJ, Jiang D, Minor MN, Chu HW. MicroRNA-21 inhibits Toll-like receptor 2 agonist-induced lung inflammation in mice. Exp Lung Res 2011;37:500-508.
35. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
36. Zarogiannis S, Gourgoulianis KI, Kostikas K. Anti-interleukin-5 therapy and severe asthma. N Engl J Med 2009;360:2576, author reply 2577.
37. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J,Wiener-Kronish JP, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011;127:372-381.
38. Newcomb DC, Peebles RS Jr. Bugs and asthma: a different disease? Proc Am Thorac Soc 2009;6:266-271.
39. Ravensberg AJ, Ricciardolo FL, van Schadewijk A, Rabe KF, Sterk PJ, Hiemstra PS, Mauad T. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 2005;115:779-785. (Pubitemid 40460853)
40. Terada N, Hamano N, Nomura T, Numata T, Hirai K, Nakajima T, Yamada H, Yoshie O, Ikeda-Ito T, Konno A. Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 2000;30:348-355. (Pubitemid 30167250)
41. Hirst SJ, Hallsworth MP, Peng Q, Lee TH. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med 2002;165:1161-1171. (Pubitemid 34415828)
42. Wright PL, Yu J, Di YP, Homer RJ, Chupp G, Elias JA, Cohn L, Sessa WC. Epithelial reticulon 4B (Nogo-B) is an endogenous regulator of Th2-driven lung inflammation. J Exp Med 2010;207:2595-2607.
43. Ghafouri B, Kihlstrom E, Tagesson C, Lindahl M. PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 2004;1699:57-63.
44. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, Zhang WL, Zhao J. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 2006;43:1864-1871.
45. Hambleton J, Weinstein SL, Lem L, DeFranco AL. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 1996;93:2774-2778.
46. Fujisawa T, Joshi BH, Puri RK. IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK/AP-1 pathway in mouse model of human ovarian cancer. Int J Cancer (In press).
47. Wu Q, Jiang D, Smith S, Thaikoottathil J, Martin RJ, Bowler RP, Chu HW. IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M. J Allergy Clin Immunol 2012;129:825-833.
48. Lorentz A, Wilke M, Sellge G, Worthmann H, Klempnauer J, Manns MP, Bischoff SC. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005;174:6751-6756. (Pubitemid 40705637)
49. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 2004;117:5965-5973. (Pubitemid 40123963)
50. van Dam H, Castellazzi M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 2001;20:2453-2464. (Pubitemid 32531302)
51. Kliment CR, Englert JM, Gochuico BR, Yu G, Kaminski N, Rosas I, Oury TD. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 2009;284:3537-3545.